PFC Recruiting for New Research Study

* There are no current open studies at PFC. Please check back again for any changes. *

MERGE study.

The Eeva Test was developed based on landmark research conducted at Stanford University¹ which discovered that early embryo growth events can predict embryo development and reflect the underlying health of the embryo. Eeva uses time-lapse video of embryos combined with unique software that analyzes embryos imaged during their earliest stages of development (from day 1 to day 3 of growth). Eeva categorizes embryos into two buckets, High and Low. Embryologists can use this information to assess embryos they have identified as candidates for transfer. An Eeva High is more likely to continue to develop; an Eeva Low is less likely to continue to develop.

PFC previously participated in the first study of Eeva. The results from the trial supported that when embryologists used Eeva in conjunction with their traditional techniques they were able to correctly identify non-viable embryos 86% of the time vs. only 58% of the time without using Eeva².

Women undergoing in vitro fertilization treatment are eligible to participate. For more information, check our research page for details on the MERGE study being conducted at PFC, or call our research team at 415-834-3000.

1 Described by Wong et al. in Nature Biotechnology, 2010.
2 Based on the Eeva System Study Development dataset results. Data on file at Auxogyn.

- Kirstin Dougall, Research

See all articles